These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3172771)

  • 1. Oestrogen receptor activation and molecular forms in human breast cancer.
    Parmar G; Elder MG; White JO
    J Steroid Biochem; 1988 Oct; 31(4A):359-64. PubMed ID: 3172771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human breast tumour cytosol oestrogen receptor binding to oligo(dT)-cellulose.
    Myatt L; White JO; Fernandez MD; Burn JI
    Br J Cancer; 1982 Jun; 45(6):964-7. PubMed ID: 7093126
    [No Abstract]   [Full Text] [Related]  

  • 3. The binding of rat uterine cytosol oestrogen receptors to oligodeoxythymidylate--cellulose. Its relationship to a stable form of receptor complex with separate ligand- and oligonucleotide-binding sites.
    Myatt L; Elder MG; Neethling C; Lim L
    Biochem J; 1982 Jan; 202(1):203-9. PubMed ID: 7082308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated oestrogen receptor in human breast cancer: clinical and biochemical correlates.
    White JO; Herschman MJ; Parmar G; Philipson KA; Elder MG; Habib NA; Wood CB
    Br J Surg; 1987 Jul; 74(7):588-90. PubMed ID: 3620866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated oestrogen receptors in breast cancer and response to endocrine therapy.
    Fernandez MD; Burn JI; Sauven PD; Parmar G; White JO; Myatt L
    Eur J Cancer Clin Oncol; 1984 Jan; 20(1):41-6. PubMed ID: 6537914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine oestrogen-receptor binding to oligo(dT)-cellulose. An inhibitor from hypothalamic cytosol.
    Shen G; Thrower S; Lim L
    Biochem J; 1979 Jul; 182(1):241-3. PubMed ID: 496911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two classes of estrogen receptors which differ in their activation mechanisms.
    Thomas T; Leung BS; Yu WC; Kiang DT
    Biochem Biophys Res Commun; 1983 Sep; 115(2):685-91. PubMed ID: 6626209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of molybdate on classification of estrogen and progesterone receptor status in human breast cancer.
    Borjesson BW; Tesoriero CJ
    J Steroid Biochem; 1985 Dec; 23(6A):949-53. PubMed ID: 4094423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogenic effect of phenol red in MCF-7 cells is achieved through activation of estrogen receptor by interacting with a site distinct from the steroid binding site.
    Rajendran KG; Lopez T; Parikh I
    Biochem Biophys Res Commun; 1987 Feb; 142(3):724-31. PubMed ID: 3827898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The selective isolation of the uterine oestradiol-receptor complex by binding to oligo(dT)-cellulose. The mediation of an essential activator in the transformation of cytosol receptor.
    Thrower S; Hall C; Lim L; Davison AN
    Biochem J; 1976 Nov; 160(2):271-80. PubMed ID: 1008856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of oestrogen receptor complexes: evidence for the distinct regulation of ligand and oligonucleotide binding sites.
    Myatt L; Cukier D; Elder MG; White JO
    Biochim Biophys Acta; 1985 May; 845(2):304-10. PubMed ID: 2986723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilisation of the cytoplasmic oestrogen receptor by molybdate.
    Krozowski ZS; Murphy LC
    J Steroid Biochem; 1981 Apr; 14(4):363-6. PubMed ID: 7230798
    [No Abstract]   [Full Text] [Related]  

  • 13. Ratio of concentrations of estrogen receptors to progesterone receptors (ER/PR) in the cytosol of breast cancers (stratification by forming of groups differing in PR).
    Hochmann J
    Neoplasma; 2007; 54(4):290-6. PubMed ID: 17822318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the effect of sodium molybdate and diisopropylfluorophosphate on the human myometrial estrogen and progesterone receptors.
    Lukola A; Punnonen R
    J Steroid Biochem; 1983 Mar; 18(3):231-5. PubMed ID: 6827828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oestrogen and progesterone receptors and response to endocrine therapy in Japanese breast cancer.
    Nomura Y; Takatani O; Sugano H; Matsumoto K
    J Steroid Biochem; 1980 May; 13(5):565-6. PubMed ID: 7392632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estradiol and progesterone receptor levels in human breast cancer in relation to cytosol and plasma estrogen level.
    Drafta D; Prişcu A; Neacşu E; Gangură M; Schindler AE; Stroe E; Anghel C; Panaitescu G
    J Steroid Biochem; 1983 Apr; 18(4):459-63. PubMed ID: 6834830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of estrogens and antiestrogens on estrogen receptor dynamics and the induction of progesterone receptor in MCF-7 human breast cancer cells.
    Eckert RL; Katzenellenbogen BS
    Cancer Res; 1982 Jan; 42(1):139-44. PubMed ID: 7053842
    [No Abstract]   [Full Text] [Related]  

  • 18. Does tamoxifen change oestrogen and progesterone receptor expression in the endometrium and breast?
    Karck U; Kommoss F
    Eur J Cancer; 2000 Sep; 36 Suppl 4():S45-6. PubMed ID: 11056315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High incidence of oestrogen receptor negative progesterone receptor positive phenotype in Indian breast cancer: fact or fiction?
    Navani S; Bhaduri AS
    Indian J Pathol Microbiol; 2005 Apr; 48(2):199-201. PubMed ID: 16758664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of oligodeoxynucleotide binding of mouse uterine cytosol estradiol receptors.
    Kumar SA; Beach TA; Dickerman HW
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3341-5. PubMed ID: 6932023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.